Results 261 to 270 of about 89,583 (305)
Some of the next articles are maybe not open access.

Propofol

2008
The hypnotic agent propofol has pharmacokinetic characteristics that allow for rapid onset and offset of drug effect and fast elimination from the body. Elderly patients show a greater sensitivity to the hypnotic effect of propofol. The drug is extensively metabolized in the liver through the cytochrome P450 system and glucuronidation, with potential ...
Vanlersberghe, C., Camu, Fréderic
openaire   +3 more sources

Propofol and the electroencephalogram

Clinical Neurophysiology, 2010
Propofol is an emulsion formulation of 2,6 diisopropylphenol developed in 1975. Widely recognized, it offers beneficial effects compared with other sedative drugs. Propofol is used in several clinical situations including multiple surgical procedures and critical-care medical conditions.
Daniel, San-juan   +2 more
openaire   +2 more sources

The pharmacology of propofol

Journal of Clinical Anesthesia, 1989
A review of the pharmacology of propofol, a new IV anesthetic agent, is presented. Solubilized in a soybean emulsion, propofol is one of a series of sterically hindered phenols that exhibit anesthetic activity. Induction of anesthesia with propofol may be associated with pain on injection, apnea, and a reduction in arterial blood pressure (BP) and ...
M A, Skues, C, Prys-Roberts
openaire   +2 more sources

Propofol

Anesthesiology, 2005
Propofol is a potent lipophilic anesthetic that was initially formulated in Cremophor El for human use. Because of the occurrence of Cremophor EL anaphylaxis and improvements in the quality of lipid emulsions, it was ultimately brought to market as 1% propofol formulated in 10% soybean oil emulsion.
Max T. Baker   +2 more
openaire   +2 more sources

Propofol-Infusionssyndrom

Der Anaesthesist, 2004
Propofol infusion syndrome has not only been observed in patients undergoing long-term sedation with propofol, but also during propofol anesthesia lasting 5 h. It has been assumed that the pathophysiologic cause is propofol's impairment of oxidation of fatty acid chains and inhibition of oxidative phosphorylation in the mitochondria, leading to lactate
J, Motsch, J, Roggenbach
openaire   +2 more sources

Endoscopist-directed propofol

Techniques in Gastrointestinal Endoscopy, 2009
Endoscopist-directed propofol (EDP) refers to delivery of propofol for endoscopic sedation under the direction of an endoscopist without any involvement of an anesthesia specialist (anesthesiologist or nurse anesthetist). EDP has been proven to be safe and is also cost-effective compared with the anesthetist delivered sedation for endoscopy.
openaire   +2 more sources

Propofol

Gastroenterology Nursing, 2006
openaire   +3 more sources

Propofol

Dimensions of Critical Care Nursing, 2001
openaire   +2 more sources

Home - About - Disclaimer - Privacy